Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin D Hedley

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cytometry. Part B, Clinical Cytometry|September 12, 2013
Determination of optimal replicate number for validation of imprecision using fluorescence cell-based assays: proposed practical methodBruce H Davis, Christine E McLaren, Anthony J Carcio, et al.
International Journal of Laboratory Hematology|November 16, 2022
T-cell clonality testing for the diagnosis of T-cell large granular lymphocytic leukemia: Are we identifying pathology or incidental clones?Benjamin Chin-Yee, Abitha Suthakaran, Benjamin D Hedley, et al.
Clinical & Experimental Metastasis|June 11, 2008
BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiationBenjamin D Hedley, Kedar S Vaidya, Pushar Phadke, et al.
Breast Cancer Research and Treatment|December 22, 2007
The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanismsErika B Schulze, Benjamin D Hedley, David Goodale, et al.
Clinical & Experimental Metastasis|January 15, 2011
The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasisJason L Townson, Ian C Macdonald, Karen T Liby, et al.
International Journal of Cancer|May 13, 2008
Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1Benjamin D Hedley, Danny R Welch, Alison L Allan, et al.
Ejhaem|November 21, 2025
Paroxysmal Nocturnal Hemoglobinuria in Pregnancy Treated With Pegcetacoplan: Case Report and Pharmacokinetic AnalysisBenjamin Chin-Yee, Benjamin D Hedley, Rui Su, et al.
Cytometry. Part B, Clinical Cytometry|July 16, 2020
A multicenter study evaluation of the ClearLLab 10C panelsBenjamin D Hedley, Guoyan Cheng, Michael Keeney, et al.
Cytometry. Part B, Clinical Cytometry|July 20, 2024
Implementation of flow cytometry testing on rare matrix samples: Special considerations and best practices when the sample is unique or difficult to obtainKatherine A Devitt, Wolfgang Kern, Malgorzata A Kajstura, et al.
Molecular Diagnosis & Therapy|April 6, 2022
Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid MalignanciesPratibha Bhai, Cyrus C Hsia, Laila C Schenkel, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cytometry. Part B, Clinical Cytometry|September 12, 2013
Determination of optimal replicate number for validation of imprecision using fluorescence cell-based assays: proposed practical methodBruce H Davis, Christine E McLaren, Anthony J Carcio, et al.
International Journal of Laboratory Hematology|November 16, 2022
T-cell clonality testing for the diagnosis of T-cell large granular lymphocytic leukemia: Are we identifying pathology or incidental clones?Benjamin Chin-Yee, Abitha Suthakaran, Benjamin D Hedley, et al.
Clinical & Experimental Metastasis|June 11, 2008
BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiationBenjamin D Hedley, Kedar S Vaidya, Pushar Phadke, et al.
Breast Cancer Research and Treatment|December 22, 2007
The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanismsErika B Schulze, Benjamin D Hedley, David Goodale, et al.
Clinical & Experimental Metastasis|January 15, 2011
The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasisJason L Townson, Ian C Macdonald, Karen T Liby, et al.
International Journal of Cancer|May 13, 2008
Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1Benjamin D Hedley, Danny R Welch, Alison L Allan, et al.
Ejhaem|November 21, 2025
Paroxysmal Nocturnal Hemoglobinuria in Pregnancy Treated With Pegcetacoplan: Case Report and Pharmacokinetic AnalysisBenjamin Chin-Yee, Benjamin D Hedley, Rui Su, et al.
Cytometry. Part B, Clinical Cytometry|July 16, 2020
A multicenter study evaluation of the ClearLLab 10C panelsBenjamin D Hedley, Guoyan Cheng, Michael Keeney, et al.
Cytometry. Part B, Clinical Cytometry|July 20, 2024
Implementation of flow cytometry testing on rare matrix samples: Special considerations and best practices when the sample is unique or difficult to obtainKatherine A Devitt, Wolfgang Kern, Malgorzata A Kajstura, et al.
Molecular Diagnosis & Therapy|April 6, 2022
Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid MalignanciesPratibha Bhai, Cyrus C Hsia, Laila C Schenkel, et al.
Pageof 4